Artículos por temáticas

Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers

Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A.

J Alzheimers Dis. 2012;31(2):265-75. doi: 10.3233/JAD-2012-111922.

Loss of synaptophysin immunoexpression in primary progressive aphasia

Lippa CF, Rosso AL.

Am J Alzheimers Dis Other Demen. 2012 Jun;27(4):250-3. doi: 10.1177/1533317512446187. Epub 2012 May 14.

The non-fluent/agrammatic variant of primary progressive aphasia

Grossman M.

Lancet Neurol. 2012 Jun;11(6):545-55. doi: 10.1016/S1474-4422(12)70099-6. Epub 2012 May 16.

The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease

Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP, Karpe F, Mackay CE.

Neurobiol Aging. 2012 Mar;33(3):618.e1-618.e13. doi: 10.1016/j.neurobiolaging.2010.11.011. Epub 2011 Jan 12.

White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions

Gold BT, Johnson NF, Powell DK, Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):416-22. doi: 10.1016/j.bbadis.2011.07.009. Epub 2011 Jul 23.

Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?

Larner AJ.

Int Psychogeriatr. 2012 Mar;24(3):391-6. doi: 10.1017/S1041610211001839. Epub 2011 Oct 3.

Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease

de Sousa OL, Amaral TF.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):119-23. doi: 10.1097/WAD.0b013e31822c5bb3.

NCAM2/OCAM/RNCAM: cell adhesion molecule with a role in neuronal compartmentalization

Winther M, Berezin V, Walmod PS.

Int J Biochem Cell Biol. 2012 Mar;44(3):441-6. doi: 10.1016/j.biocel.2011.11.020. Epub 2011 Dec 2.

Dementia, stroke, and vascular risk factors; a review

Sahathevan R, Brodtmann A, Donnan GA.

Int J Stroke. 2012 Jan;7(1):61-73. doi: 10.1111/j.1747-4949.2011.00731.x.

Assessment of cognition, physical performance, and gait in the context of mild cognitive impairment and dementia

Bruce-Keller AJ, Brouillette RM, Tudor-Locke C, Foil HC, Gahan WP, Correa J, Nye DM, Keller JN.

J Am Geriatr Soc. 2012 Jan;60(1):176-7. doi: 10.1111/j.1532-5415.2011.03762.x.

Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis

Guan F, Gu J, Hu F, Zhu Y, Wang W.

Mol Biol Rep. 2012 Jun;39(6):6661-9. doi: 10.1007/s11033-012-1472-8.

Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review

Seitz DP, Brisbin S, Herrmann N, Rapoport MJ, Wilson K, Gill SS, Rines J, Le Clair K, Conn D.

J Am Med Dir Assoc. 2012 Jul;13(6):503-506.e2. doi: 10.1016/j.jamda.2011.12.059. Epub 2012 Feb 17.

Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database

Spering CC, Hobson V, Lucas JA, Menon CV, Hall JR, O'Bryant SE.

J Gerontol A Biol Sci Med Sci. 2012 Aug;67(8):890-6. doi: 10.1093/gerona/gls006. Epub 2012 Mar 6.

Microembolism, silent brain infarcts and dementia

Goldberg I, Auriel E, Russell D, Korczyn AD.

J Neurol Sci. 2012 Nov 15;322(1-2):250-3. doi: 10.1016/j.jns.2012.02.021. Epub 2012 Mar 17.

Investigating missing data in Alzheimer disease studies

Schott JM, Bartlett JW.

Neurology. 2012 May 1;78(18):1370-1. doi: 10.1212/WNL.0b013e318253d66b. Epub 2012 Apr 4.